InvestorsObserver is giving Teva Pharmaceutical Industries Ltd (TEVA) an Analyst Rating Rank of 13, meaning TEVA is ranked higher by analysts than 13% of stocks. The average price target for TEVA is $10.125 and analyst’s rate the stock as a Buy.
Wall Street analysts are rating TEVA a Buy today. Find out what this means to you and get the rest of the rankings on TEVA!